Bain utilise des cookies pour améliorer la fonctionnalité et la performance de ce site. En poursuivant votre navigation suce site, vous acceptez l’utilisation des cookies. Pour plus d’informations, veuillez-vous référer à notre politique de confidentialité

We have French content available. View French site.

Étude de cas

Review focuses biotech on portfolio potential

This biotech client was managing a complex product portfolio with significant revenue but only breakeven profitability. Bain performed a comprehensive portfolio review that resulted in clear project-level recommendations to refocus the company's resources on projects with the highest potential.

  • min

Toute l’histoire

The Situation

  • BiotechCo* is a research-based pharmaceutical company that develops and commercializes drugs in several therapeutic areas
  • BiotechCo has several products on the market and about a dozen in different stages of development
  • The company has significant revenue from royalties and marketed products, with breakeven profitability
  • BiotechCo's drug portfolio is increasingly complex and difficult to manage
  • Public pressure is being applied by investors calling for strategic moves to jolt the stock out of its current range

 

Our Approach

Combine strategic priorities with project and process evaluation:

Our Recommendations

Review the highest-priority opportunities for strategic fit:

The Results

Refocus resources on highest potential projects:

 

* We take our clients' confidentiality seriously. While we've changed their names, the results are real. 

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.